NeoMed Management Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals
  • Investments
  • 79

  • Portfolio
  • 4

  • Exits
  • 50

Exits

NeoMed Management General Information

Description

Founded in 1997, NeoMed Management is a venture capital firm based in Oslo, Norway. The firm focuses on investments in the healthcare, pharmaceutical, medical device and diagnostic sectors. It invests predominantly in Europe and selectively in North America in companies.

Contact Information

Website
www.neomed.net
Year Founded
1997
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • IFC 5
  • St Helier, NJ
  • United States

NeoMed Management Investments (79)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Oxular 01-Mar-2021 Later Stage VC 000.00 Drug Discovery Generating Revenue 0000 00000 00.0
000000000 00000000 05-Feb-2020 00 000000000 0000 Therapeutic Devices Generating Revenue 0000 00000 00.0
0000000 0000000 22-Jan-2020 0000 000.00 Therapeutic Devices Generating Revenue/Not Profitable 000000 000000 00.0
0000000 26-Dec-2019 00 000000000 000.00 Surgical Devices Generating Revenue/Not Profitable
000 0000000 000000 18-Oct-2018 0000000000 Enterprise Systems (Healthcare) Generating Revenue 0000 00000 00.0
00 000000000000000 21-Sep-2018 00000 00000 0000 Biotechnology Generating Revenue/Not Profitable
0000000 11-Apr-2018 00000 00000 000.00 Therapeutic Devices Generating Revenue/Not Profitable 0000 00000 00.0
0000000 18-Sep-2017 00 000000000 0000 Surgical Devices Generating Revenue/Not Profitable 0000 00000 00.0
Avitide 26-Jun-2017 Later Stage VC 0000 Biotechnology Generating Revenue 0000000 00000 00.0
Sonendo 16-May-2017 Later Stage VC 0000 Surgical Devices Generating Revenue/Not Profitable 0000 00000 00.0
You’re viewing 10 of 79 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeoMed Management Exits (50)

Company Name Exit Date Exit Type Exit Size
Gelesis 13-Jan-2022 Reverse Merger 00000
0000000 29-Oct-2021 000 000.00
0000000 30-Sep-2021 000000000000000000 00000
0000000000 05-Feb-2021 000 00000
00000000 18-Jan-2021 000 00 00000000
000000 00000000000 17-Sep-2019 0000000000: 000000
0000000 0000000 11-Feb-2019 000 000.00
0000000 31-Oct-2018 000 00000
Wilson Therapeutics 25-May-2018 Merger/Acquisition 00000
TandemLife 04-Apr-2018 Merger/Acquisition 00000
You’re viewing 10 of 50 exits. Get the full list »

NeoMed Management Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore NeoMed Management‘s full profile, request access.

Request a free trial

NeoMed Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NeoMed Management Team (13)

Name Title Deals Funds Boards Office
Dina Chaya Ph.D Partner 0 0 0 Geneva, Switzerland
Thomas Goebel Ph.D Principal 0 0 0 Geneva, Switzerland
Pål Jensen Director of Finance 0 Oslo, Norway
Erik Amble Ph.D Founder, Partner & Chairman 00 0 0 Oslo, Norway
Claudio Nessi Ph.D Managing Partner 00 0 0 Geneva, Switzerland
You’re viewing 5 of 13 team members. Get the full list »

NeoMed Management Co-Investors (3)

Name With Exits Lead Partner Series Industry
Forbion 1 0 Series chart Industry bar
IP Group 0 0 Series chart Industry bar
V-Bio Ventures 0 0 Series chart Industry bar
To view NeoMed Management’s complete co-investors history, request access »